Showing results 22 to 41 of 85
< previous
next >
| Issue Date | Title | Author(s) |
| 2019 | Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: Protocol for a systematic review of economic evaluations | Elliott, J; McCoy, B; Clifford, T; Potter, BK; Skidmore, B; Wells, GA; Coyle, D |
| 2017 | Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD | Huber, M; Präger, M; Coyle, K; Coyle, D; Lester-George, A; Trapero-Bertran, M; Nemeth, B; Cheung, KL; Stark, R; Vogl, M; Pokhrel, S; Leidl, R |
| 12-Aug-2022 | Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting | Scarffe, AD; Licskai, CJ; Ferrone, M; Brand, K; Thavorn, K; Coyle, D |
| 30-Jan-2018 | Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada. | Coyle, D |
| 2017 | A cost-utility analysis of risk model-guided versus physician’s choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach | Coyle, D; Hoch, JS; Vandermeer, L; Mazzarello, S; Wang, Z; Dranitsaris, G; Fergusson, D; Clemons, M |
| 2016 | Costs of disinvesting from stop smoking services: an economic evaluation based on the NICE Tobacco Return on Investment model | Pokhrel, S; Owen, L; Coyle, K; Lester-George, A; Leng, G; West, R; Coyle, D |
| 12-Jun-2025 | Decision Frameworks for Assessing Cost-Effectiveness Given Previous Nonoptimal Decisions | Coyle, D; Glynn, D; Goldhaber-Fiebert, JD; Wilson, ECF |
| 2016 | Designing economic evaluations to facilitate optimal decisions: The need to avoid bias | Lee, KM; Coyle, K; Coyle, D |
| 2010 | Determining utility values related to malaria and malaria chemoprophylaxis | McCarthy, AE; Coyle, D |
| 18-Aug-2017 | Development and Application of an Economic Model (EQUIPTMOD) to assess the Impact of Smoking Cessation | Coyle, K; Coyle, D; Lester-George, A; West, R; Nemeth, B; Hiligsmann, M; Trapero-Bertran, M; Leidl, R; Pokhrel, S |
| 2018 | Development of a descriptive system for patient experience | Singh, Jeshika |
| 2014 | Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada | Mullen, K-A; Coyle, D; Manuel, D; Nguyen, HV; Ba', P; Pipe, AL; Reid, RD |
| 27-Sep-2019 | Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts | Coyle, D; Villeneuve, PJA |
| 2013 | Effect of folic acid supplementation in pregnancy on preeclampsia: The folic acid clinical trial study | Wen, SW; Champagne, J; Rennicks White, R; Coyle, D; Fraser, W; Smith, G; Fergusson, D; Walker, MC |
| 12-Sep-2018 | Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): Double blind, phase III, randomised controlled, international, multicentre trial | Wen, SW; White, RR; Rybak, N; Gaudet, LM; Robson, S; Hague, W; Simms-Stewart, D; Carroli, G; Smith, G; Fraser, WD; Wells, G; Davidge, ST; Kingdom, J; Coyle, D; Fergusson, D; Corsi, DJ; Champagne, J; Sabri, E; Ramsay, T; Mol, BWJ; Oudijk, MA; Walker, MC |
| 3-May-2019 | Effect of implementation of the MORE <sup>OB</sup> program on adverse maternal and neonatal birth outcomes in Ontario, Canada: A retrospective cohort study | Weiss, D; Fell, DB; Sprague, AE; Walker, MC; Dunn, S; Reszel, J; Peterson, WE; Coyle, D; Taljaard, M |
| 2016 | Effectiveness of a hospital-initiated smoking cessation programme: 2-year health and healthcare outcomes | Mullen, KA; Manuel, DG; Hawken, SJ; Pipe, AL; Coyle, D; Hobler, LA; Younger, J; Wells, GA; Reid, RD |
| 2014 | EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control | Pokhrel, S; Evers, S; Leidl, R; Trapero-Bertran, M; Kalo, Z; Vries, HD; Crossfield, A; Andrews, F; Rutter, A; Coyle, K; Lester-George, A; West, R; Owen, L; Jones, T; Vogl, M; Radu-Loghin, C; Voko, Z; Huic, M; Coyle, D |
| 2017 | Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys. | Potter, BK; Hutton, B; Clifford, TJ; Pallone, N; Smith, M; Stockler, S; Chakraborty, P; Barbeau, P; Garritty, CM; Pugliese, M; Rahman, A; Skidmore, B; Tessier, L; Tingley, K; Coyle, D; Greenberg, CR; Korngut, L; MacKenzie, A; Mitchell, JJ; Nicholls, S; Offringa, M; Schulze, A; Taljaard, M; Canadian Inherited Metabolic Diseases Research Network |
| 2017 | Estimates of effectiveness and reach for ‘return on investment’ modelling of smoking cessation interventions using data from England | West, R; Coyle, K; Owen, L; Coyle, D; Pokhrel, S |
